- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Draf III Procedure in Korea, Republic of
Total 445 results
-
Seoul National University HospitalFurun MedicalUnknownUrinary Incontinence | Exercise | Prostate Neoplasm | Pelvic Floor | Prostatectomy | Biofeedback | Surgical Procedures, RoboticKorea, Republic of
-
Yonsei UniversityCompletedEpilepsy and Focal Cortical Dysplasia IIKorea, Republic of
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
Pusan National University HospitalPusan National University Yangsan HospitalUnknownElective Surgery of Gastrointestinal Tract | 100 Adults Aged Between 20 and 70 Years Old | ASA Physical Status of I or IIKorea, Republic of
-
Samsung Medical CenterUnknownStage IIIA Non-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCytoGen, Inc.; UNIST (Ulsan National Institute of Science and Technology)Active, not recruitingNSCLC Stage IV | NSCLC Stage IIIBKorea, Republic of
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage...United States, South Africa
-
Isfahan University of Medical SciencesUnknownProcedural SedationIran, Islamic Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownType II DiabetesKorea, Republic of
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II Diabetes MellitusKorea, Republic of
-
BayerCompleted
-
Aesculap AGB.Braun Surgical SATerminatedGastrointestinal Neoplasms | Symptomatic Disorders of the Gastrointestinal Tract | Gastric Anastomosis (Site) | C.Surgical Procedure; Digestive SystemPhilippines, Malaysia, Korea, Republic of, Taiwan
-
Yonsei UniversityActive, not recruitingLarynx | Stage II-IVB Operable HNSCC Oral Cavity | Hypopharynx | OropharynxKorea, Republic of
-
HucircadianPusan National University Hospital; Korea University Guro Hospital; Korea University... and other collaboratorsRecruitingMajor Depressive Disorder | Bipolar 1 Disorder | Bipolar II DisorderKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedDyslipidemia | Type II DiabetesKorea, Republic of
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
Merck KGaA, Darmstadt, GermanyMerck Ltd.CompletedHypertension | Diabetes Mellitus, Type IIKorea, Republic of
-
Seoul National University Bundang HospitalSeoul St. Mary's Hospital; Asan Medical Center; Seoul National University Hospital and other collaboratorsRecruitingEndovascular Procedures | Aneurysm CerebralKorea, Republic of
-
Medstar Health Research InstituteCardinal HealthCompletedCardiac Diagnostic Procedure | Cardiac Interventional Procedure | Femoral Access Site ClosureUnited States
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Samsung Medical CenterTerminatedPhase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinKorea, Republic of
-
Seoul National University HospitalRecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer... and other conditionsUnited States
-
Samsung Medical CenterUnknownNasophayngeal Carcinoma Between Stage II and IVbKorea, Republic of
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Seagen Inc.RecruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditionsUnited States, Canada, Puerto Rico
-
Zealand University HospitalRecruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Chong Kun Dang PharmaceuticalCompletedType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Green Cross CorporationCompleted
-
Green Cross CorporationCompleted
-
Green Cross CorporationUnknownThe Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) PatientsHunter SyndromeKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
Yonsei UniversityNational Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaboratorsUnknownOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
CanariaBio Inc.Korean Cancer Study GroupRecruitingOvarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer by FIGO StageKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
GC Biopharma CorpRecruitingMucopolysaccharidosis II | Hunter SyndromeKorea, Republic of
-
Yuhan CorporationCompletedDyslipidemia | Type II DiabetesKorea, Republic of